Program Description:
This educational activity is designed to provide a learning environment that provides interactive discussions on up to date medical information, treatment plans, options and protocols, along with the risks, benefits and outcomes of treatment on adult musculoskeletal oncology patients. This is a discussed in a multidisciplinary format that creates a well rounded unbiased discussion amongst colleagues. It creates an environment for dynamic discussion and debates on patient care and the treatment resources available. It provides the opportunity for consistent tailored individual treatment protocols per patient.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience:
Physician
Physician (fellow/resident)
Physician Assistant
Nurse
Nurse Practitioner
AP/NP
Allied Health Care Professionals
Learning objectives:
- Apply recent updates to treatment plans and protocols based on the discussions of the patient’s treatment at tumor board
- Expand our discussions to include the most recent and relevant literature evaluations on musculoskeletal oncology and disease protocols and treatment outcomes
- Continue to collaborate as a multidisciplinary unit to treat the patient as a whole and utilize treatment resources efficiently
- Publish research that is up to date and relevant to current literature
Faculty & credentials:
All persons in control of content have NO relevant financial relationships to disclose except:
Name: | Company: | Role: |
Don Hackbarth, MD Pete Rossi, MD
Sean Tutton, MD
Brandon Rebholz, MD John Neilson, MD | MTF Biologics Silk Road Medical Termo Aortic Stryker BTG/BSC Zimmer/Biomet MTF | Board of Directors Speaker Consultant Consultant Consultant Consultant Board Member |
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
Contact
Session date:
06/03/2020 - 7:45am to 8:45am CDT
Location:
Froedtert Hospital - Cancer Center
9200 W. Wisconsin Avenue
Room L
Milwaukee, WI
53226
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.